Edwards Lifesciences (EW) Net Cash Flow (QoQ) (2009 - 2026)
Edwards Lifesciences (EW) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 191.64% |
| Mar 31, 2026 | -307.38% |
| Dec 31, 2025 | 140.59% |
| Sep 30, 2025 | -447.89% |
| Jun 30, 2025 | 58.59% |
| Mar 31, 2025 | 115.94% |
| Dec 31, 2024 | -132.53% |
| Sep 30, 2024 | 419.59% |
| Jun 30, 2024 | 460.59% |
| Mar 31, 2024 | 127.16% |
| Dec 31, 2023 | -173.49% |
| Sep 30, 2023 | 129.12% |
| Jun 30, 2023 | 44.35% |
| Mar 31, 2023 | 123.43% |
| Dec 31, 2022 | -1,297.14% |
| Sep 30, 2022 | -74.95% |
| Jun 30, 2022 | -0.65% |
| Mar 31, 2022 | 123.64% |
| Dec 31, 2021 | -438.14% |
| Sep 30, 2021 | 40.63% |